Monthly Archives: June 2025

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer
June 24, 2025

Independent DSMB identifies no safety concerns, and recommends continuation of BriaCell’s pivotal Phase 3 study ...

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26
June 4, 2025

PHILADELPHIA and VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: ...

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025
June 2, 2025

Three BriaCell posters and one publish-only abstract highlight robust clinical data from Bria-IMT™ and Bria-OTS™ ...

Skip to content